Compound K-induced apoptosis of human hepatocellular carcinoma MHCC97-H cells in vitro

Oncology Reports

Volumn 32, Issue 1, 2014, Pages 325-331

  Zheng, Zhi Zhong ^a   Ming, Yan Lin ^a,b   Chen, Liang Hua ^a,b   Zheng, Guo Hua ^a   Liu, Shao Song ^a   Chen, Qing Xi ^b  

^a Xiamen Oversea Chinese Subtropical Plant Introduction Garden   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Apoptosis; Compound K; Fas FasL; Human hepatocellular carcinoma; MHCC97 H; Mitochondria

Indexed keywords

20 O (BETA DEXTRO GLUCOPYRANOSYL) PROTOPANAXADIOL; ANTINEOPLASTIC AGENT; FAS ANTIGEN; FAS LIGAND; PROCASPASE 3; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG; GINSENOSIDE; GINSENOSIDE M1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOSIS INHIBITION; MTT ASSAY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIVER CELL CARCINOMA; LIVER TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GINSENOSIDES; HUMANS; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL;

EID: 84903118619     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3171     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156, 2001. (Pubitemid 32911406)
2. Ogunbiyi JO: Hepatocellular carcinoma in the developing world. Semin Oncol 28: 179-187, 2001.
3. Cotter TG: Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 9: 501-507, 2009.
4. Choi HH, Jong HS, Park JH, et al: A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells. Int J Oncol 23: 1087-1093, 2003.
5. Hu C, Song G, Zhang B, Liu Z, Chen R, Zhang H and Hu T: Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway. J Cell Mol Med 16: 96-106, 2011.
6. Attele AS, Wu JA and Yuan CS: Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693, 1999. (Pubitemid 29505408)
7. Joh EH, Lee IA, Jung IH and Kim DH: Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation - the key step of inflammation. Biochem Pharmacol 82: 278-286, 2011.
8. Kobashi K and Akao T: Relation of intestinal bacteria to pharmacological effects of glycosides. Bioscience Microflora 16: 1-7, 1997.
9. Wakabayashi C, Hasegawa H, Murata J and Saiki I: The expression of in vivo antimetastatic effect of ginseng protopanaxatriol saponins is mediated by their intestinal bacterial metabolites after oral administration. J Traditional Med 14: 180-185, 1997.
10. Wakabayashi C, Hasegawa H, Murata J and Saiki I: In vivo anti-metastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res 9: 411-417, 1997. (Pubitemid 127825994)
11. Akao T, Kanaoka M and Kobashi K: Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay. Biol Pharm Bull 21: 245-249, 1998. (Pubitemid 28166911)
12. Wang CZ, Kim KE, Du GJ, et al: Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma. Am J Chin Med 39: 1161-1171, 2011.
13. Tsutsumi YM, Tsutsumi R, Mawatari K, Nakaya Y, Kinoshita M, Tanaka K and Oshita S: Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway. Life Sci 88: 725-729, 2011.
14. Choo MK, Sakurai H, Kim DH and Saiki I: A ginseng saponin metabolite suppresses tumor necrosis factor-α-promoted metastasis by suppressing nuclear factor-κB signaling in murine colon cancer cells. Oncol Rep 19: 595-600, 2008. (Pubitemid 351330423)
15. Kim DY, Yuan HD, Chung IK and Chung SH: Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J Agric Food Chem 57: 1532-1537, 2009.
16. Lee BH, Lee SJ, Hur JH, Lee S, Sung JH, Huh JD and Moon CK: In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Med 64: 500-503, 1998. (Pubitemid 28383879)
17. Lee SJ, Sung JH, Lee SJ, Moon CK and Lee BH: Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 144: 39-43, 1999.
18. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M, Inouye Y, Kasai R and Yamasaki K: Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med 61: 409-413, 1995.
19. Ming YL, Song G, Chen LH, et al: Anti-proliferation and apoptosis induced by a novel intestinal metabolite of ginseng saponin in human hepatocellular carcinoma cells. Cell Biol Int 31: 1265-1273, 2007. (Pubitemid 47039229)
20. Cossarizza A, Baccarani-Contri M, Kalashnikova G and Franceschi C: A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′- tetrachloro-1,1′,3,3′-tetraethyl-benzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197: 40-45, 1993. (Pubitemid 23358874)
21. Collins AR, Dobson VL, Dusinska M, Kennedy G and Stetina R: The comet assay: what can it really tell us? Mutat Res 375: 183-193, 1997. (Pubitemid 27226696)
22. 2+-dependent DNA damage in human peripheral blood lymphocytes. Free Radic Biol Med 26: 548-556, 1999.
23. Hasegawa H: Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 95: 153-157, 2004.
24. Lee JY, Shin JW, Chun KS, et al: Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 26: 359-367, 2005.
25. Ming YL, Zheng ZZ, Chen LH and Tong QX: Apoptosis induced by a novel intestinal metabolite of ginseng saponin in human hepatocellular carcinoma BEL-7402 cells. Chin Trad Herbal Drugs 38: 1511-1514, 2007.
26. Qi F, Li A, Inagaki Y, et al: Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food Chem Toxicol 50: 295-302, 2012.
27. Vaithinathan S, Saradha B and Mathur PP: Methoxychlor induces apoptosis via mitochondria- and FasL-mediated pathways in adult rat testis. Chem Biol Interact 185: 110-118, 2010.
28. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 33: 29-55, 1999.
29. Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM and Gottlieb E: BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ 18: 538-548, 2011.
30. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794-2804, 1997. (Pubitemid 27226216)
31. Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
32. Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157, 1996. (Pubitemid 26256586)
33. Srinivasula SM, Ahmad M, Fernandes-Alnemri T and Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1: 949-957, 1998. (Pubitemid 128379256)
34. Slee EA, Harte MT, Kluck RM, et al: Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144: 281-292, 1999. (Pubitemid 29066031)
35. Jeong SJ, Dasgupta A, Jung KJ, Um JH, Burke A, Park HU and Brady JN: PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 370: 264-272, 2008. (Pubitemid 350199679)
36. Moon DO, Park SY, Choi YH, Kim ND, Lee C and Kim GY: Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 51: 112-120, 2008.
37. Oh SH, Yin HQ and Lee BH: Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells. Arch Pharm Res 27: 402-406, 2004.